164 related articles for article (PubMed ID: 20136653)
1. Animal models of amyloid-beta-related pathologies in Alzheimer's disease.
Philipson O; Lord A; Gumucio A; O'Callaghan P; Lannfelt L; Nilsson LN
FEBS J; 2010 Mar; 277(6):1389-409. PubMed ID: 20136653
[TBL] [Abstract][Full Text] [Related]
2. Targeted introduction of V642I mutation in amyloid precursor protein gene causes functional abnormality resembling early stage of Alzheimer's disease in aged mice.
Kawasumi M; Chiba T; Yamada M; Miyamae-Kaneko M; Matsuoka M; Nakahara J; Tomita T; Iwatsubo T; Kato S; Aiso S; Nishimoto I; Kouyama K
Eur J Neurosci; 2004 May; 19(10):2826-38. PubMed ID: 15147316
[TBL] [Abstract][Full Text] [Related]
3. Magnetic resonance imaging of Alzheimer's pathology in the brains of living transgenic mice: a new tool in Alzheimer's disease research.
Jack CR; Marjanska M; Wengenack TM; Reyes DA; Curran GL; Lin J; Preboske GM; Poduslo JF; Garwood M
Neuroscientist; 2007 Feb; 13(1):38-48. PubMed ID: 17229974
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic targets from a Drosophila model of Alzheimer's disease.
Crowther DC; Kinghorn KJ; Page R; Lomas DA
Curr Opin Pharmacol; 2004 Oct; 4(5):513-6. PubMed ID: 15351357
[TBL] [Abstract][Full Text] [Related]
5. The amyloid peptide and its precursor in Alzheimer's disease.
Octave JN
Rev Neurosci; 1995; 6(4):287-316. PubMed ID: 8845971
[TBL] [Abstract][Full Text] [Related]
6. Novel amyloid precursor protein gene mutation (codon 665Asp) in a patient with late-onset Alzheimer's disease.
Peacock ML; Murman DL; Sima AA; Warren JT; Roses AD; Fink JK
Ann Neurol; 1994 Apr; 35(4):432-8. PubMed ID: 8154870
[TBL] [Abstract][Full Text] [Related]
7. A decade of modeling Alzheimer's disease in transgenic mice.
McGowan E; Eriksen J; Hutton M
Trends Genet; 2006 May; 22(5):281-9. PubMed ID: 16567017
[TBL] [Abstract][Full Text] [Related]
8. Animal models of Alzheimer's disease and frontotemporal dementia.
Götz J; Ittner LM
Nat Rev Neurosci; 2008 Jul; 9(7):532-44. PubMed ID: 18568014
[TBL] [Abstract][Full Text] [Related]
9. Temporal memory deficits in Alzheimer's mouse models: rescue by genetic deletion of BACE1.
Ohno M; Chang L; Tseng W; Oakley H; Citron M; Klein WL; Vassar R; Disterhoft JF
Eur J Neurosci; 2006 Jan; 23(1):251-60. PubMed ID: 16420434
[TBL] [Abstract][Full Text] [Related]
10. Mutation of the beta-amyloid precursor protein in familial Alzheimer's disease increases beta-protein production.
Citron M; Oltersdorf T; Haass C; McConlogue L; Hung AY; Seubert P; Vigo-Pelfrey C; Lieberburg I; Selkoe DJ
Nature; 1992 Dec; 360(6405):672-4. PubMed ID: 1465129
[TBL] [Abstract][Full Text] [Related]
11. A beta peptide vaccination prevents memory loss in an animal model of Alzheimer's disease.
Morgan D; Diamond DM; Gottschall PE; Ugen KE; Dickey C; Hardy J; Duff K; Jantzen P; DiCarlo G; Wilcock D; Connor K; Hatcher J; Hope C; Gordon M; Arendash GW
Nature; 2000 Dec 21-28; 408(6815):982-5. PubMed ID: 11140686
[TBL] [Abstract][Full Text] [Related]
12. C. elegans models of age-associated neurodegenerative diseases: lessons from transgenic worm models of Alzheimer's disease.
Link CD
Exp Gerontol; 2006 Oct; 41(10):1007-13. PubMed ID: 16930903
[TBL] [Abstract][Full Text] [Related]
13. Alzheimer-type neuropathology in transgenic mice overexpressing V717F beta-amyloid precursor protein.
Games D; Adams D; Alessandrini R; Barbour R; Berthelette P; Blackwell C; Carr T; Clemens J; Donaldson T; Gillespie F
Nature; 1995 Feb; 373(6514):523-7. PubMed ID: 7845465
[TBL] [Abstract][Full Text] [Related]
14. [The pathogenesis of Alzheimer's disease demonstrated by immunocytochemistry with anti-beta-protein antibody].
Ikeda S
Yakubutsu Seishin Kodo; 1992 Jun; 12(3):141-9. PubMed ID: 1414034
[TBL] [Abstract][Full Text] [Related]
15. Transgenic mouse models of Alzheimer's disease: phenotype and application.
Higgins GA; Jacobsen H
Behav Pharmacol; 2003 Sep; 14(5-6):419-38. PubMed ID: 14501255
[TBL] [Abstract][Full Text] [Related]
16. A pathogenic mutation for probable Alzheimer's disease in the APP gene at the N-terminus of beta-amyloid.
Mullan M; Crawford F; Axelman K; Houlden H; Lilius L; Winblad B; Lannfelt L
Nat Genet; 1992 Aug; 1(5):345-7. PubMed ID: 1302033
[TBL] [Abstract][Full Text] [Related]
17. The amyloid peptide precursor in Alzheimer's disease.
Octave JN
Acta Neurol Belg; 1995 Dec; 95(4):197-209. PubMed ID: 8553793
[TBL] [Abstract][Full Text] [Related]
18. Intraneuronal amyloid beta and reduced brain volume in a novel APP T714I mouse model for Alzheimer's disease.
Van Broeck B; Vanhoutte G; Pirici D; Van Dam D; Wils H; Cuijt I; Vennekens K; Zabielski M; Michalik A; Theuns J; De Deyn PP; Van der Linden A; Van Broeckhoven C; Kumar-Singh S
Neurobiol Aging; 2008 Feb; 29(2):241-52. PubMed ID: 17112635
[TBL] [Abstract][Full Text] [Related]
19. Transgenic potato expressing Abeta reduce Abeta burden in Alzheimer's disease mouse model.
Youm JW; Kim H; Han JH; Jang CH; Ha HJ; Mook-Jung I; Jeon JH; Choi CY; Kim YH; Kim HS; Joung H
FEBS Lett; 2005 Dec; 579(30):6737-44. PubMed ID: 16310782
[TBL] [Abstract][Full Text] [Related]
20. [Molecular basics of Alzheimer's disease].
Grigorenko AP; Rogaev EI
Mol Biol (Mosk); 2007; 41(2):331-45. PubMed ID: 17514900
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
